Associate Director, Global Pricing Strategy & Analytics
Revolution Medicines - Remote (United States)
Posted Apr 24, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified
- Salary
- Not verified not verified - source not recorded; timestamp not recorded
- 401(k) match
- Not verified
Was this benefit information wrong? Tell us.
Market context
- Median wage (BLS OEWS)
- $111,944 national median
- Projected growth (BLS Employment Projections)
- +13.7% - Much faster than average
78% above the BLS national median for data and ml aggregate.
Matched to SOC 15-1252 - Data and ML aggregate by role bucket.
Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Associate Director, Global Pricing Strategy & Analytics Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Global Pricing Strategy & Analytics will play a critical role in shaping and executing global pricing strategies across the portfolio. This individual will lead the development of pricing frameworks, provide advanced analytics, and generate insights to support value optimization and market access decisions. The role requires strong cross-functional collaboration with Market Access, Commercial, Finance, HEOR, and Regional teams to ensure pricing strategies are aligned with business objectives and external market dynamics. Key Responsibilities: Global Pricing Strategy - Support the development and execution of global pricing strategies for pipeline products across key markets. - Establish pricing guidance, guardrails, and launch sequencing strategies to optimize global value. - Evaluate pricing scenarios considering payer dynamics, competitive landscape, and regulatory constraints. - Support early asset strategy by integrating pricing considerations into clinical and commercial planning. Analytics & Insights - Design and deliver advanced
Read the full description at www.revmed.com. FewerJobs shows a source-linked preview and links to the original posting.
Apply link not verified; last-live date unavailable.
What verified means
Verified means a displayed claim has a recorded source field, a source URL when available, and a timestamp showing when FewerJobs checked or enriched the evidence.
Related jobs
-
Space Mission Ground Simulator - Principal / Sr Principal Systems Engineer
Northrop Grumman - United States-Maryland-Linthicum
-
Principal Engineer Reliability
Northrop Grumman - United States-California-Sunnyvale
-
Mission Assurance Engineer /Principal Mission Assurance Engineer
Northrop Grumman - United States-Utah-Clearfield
-
Sr. Principal Cyber Systems / Network Engineer
Northrop Grumman - VAFA09GC